Skip to main content
Clinical Trials/NCT07293702
NCT07293702Not yet recruitingNot Applicable

**Effect of Instrument-Assisted Soft Tissue Mobilization on Pain, Functionality, and Proprioception in Individuals With Subacromial Impingement Syndrome**

Istanbul Medipol University Hospital1 site in 1 country38 target enrollmentStarted: December 25, 2025Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
38
Locations
1
Primary Endpoint
Visual Analog Scale

Study Overview

Brief Summary

The aim of this study will be to investigate the effects of Instrument-Assisted Soft Tissue Mobilization (IASTM), applied in addition to a conventional exercise program, on pain, range of motion, proprioception, functionality, and quality of life in individuals with Subacromial Impingement Syndrome (SIS).

Detailed Description

The aim of this study will be to investigate the effects of Instrument-Assisted Soft Tissue Mobilization (IASTM), applied in addition to a conventional exercise program, on pain, range of motion, proprioception, functionality, and quality of life in individuals with Subacromial Impingement Syndrome (SIS).

A total of 38 participants will be included in the study and will be randomly assigned to either the Conventional Exercise Group or the IASTM Group. Both groups will receive treatment for 4 weeks, three sessions per week, for a total of 12 sessions.

Before the intervention, both groups will be assessed for pain (VAS), range of motion (goniometer), joint position sense (goniometer), functionality (Disabilities of the Arm, Shoulder and Hand - DASH), and quality of life (Rotator Cuff Quality of Life - RC-QoL).

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Participant)

Eligibility Criteria

Ages
40 Years to 60 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Individuals diagnosed with SIS by MRI
  • Men and women between 40 and 60 years of age
  • Individuals with symptoms persisting for at least one month
  • Individuals with a minimum of 60° of shoulder flexion and abduction range of motion

Exclusion Criteria

  • Individuals with a history of surgery on the affected arm
  • Individuals with an open wound on the arm
  • Individuals with an active infection
  • Individuals with inflammatory joint disease
  • Individuals with malignant or benign tumors were excluded from the study.

Outcomes

Primary Outcomes

Visual Analog Scale

Time Frame: From enrollment to the end of treatment at 4 weeks

The Visual Analog Scale (VAS) is a tool used to measure pain intensity as a single-dimensional construct across different adult populations. It typically consists of a horizontal or vertical line measuring 10 cm in length. On this scale, a score of 0 indicates no pain, while a score of 10 represents the worst pain imaginable.

Range of motion

Time Frame: From enrollment to the end of treatment at 4 weeks

Shoulder flexion, abduction, internal rotation, and external rotation range of motion will be assessed using a universal goniometer while the patient is positioned in supine and performs the movements actively.

The Disabilities of the Arm, Shoulder and Hand (DASH)

Time Frame: From enrollment to the end of treatment at 4 weeks

The Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire is a scale that evaluates functional status and capability following injuries or disorders affecting the upper extremity. The DASH consists of 30 items. These items assess difficulties encountered during specific tasks, as well as pain, numbness, stiffness, weakness, sleep problems, self-confidence, and participation in social activities. Scores range from 0 to 100, with higher scores indicating greater impairment in upper extremity function.

Secondary Outcomes

  • Joint position sense(From enrollment to the end of treatment at 4 weeks)
  • Rotator cuff quality of life Index(From enrollment to the end of treatment at 4 weeks)

Investigators

Sponsor
Istanbul Medipol University Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

burak menek

Principal Investigator

Istanbul Medipol University Hospital

Study Sites (1)

Loading locations...

Similar Trials